MicroRNA Market Poised for Explosive Growth: Size to Reach Over $ 2977.79 Million by 2030
A recent Infinium Global Research report dives deep into the microRNA market, analyzing its various segments and sub-segments across the globe and in specific regions. It explores the factors that influence this market, both positive (drivers) and negative (restraints), along with considering the influence of broader economic trends (macro indicators) in the short and long term. The report provides a comprehensive picture of current trends, forecasts, and the overall market value of microRNAs globally.
Ask for the Latest Research Report Sample@ https://tinyurl.com/22dml64k
MicroRNAs: Tiny Molecules, Big Impact
The market for microRNAs, tiny RNA molecules crucial for gene regulation, is expected to grow significantly. Estimated at $1.22 billion USD in 2022, the market is projected to reach $2.98 billion USD by 2030, reflecting a Compound Annual Growth Rate (CAGR) of 12.25% between 2023 and 2030.
These microRNAs (miRNAs) bind to messenger RNAs (mRNAs), essentially preventing them from creating proteins. Discovered in 1993 during research on the gene lin-14 in C. elegans, miRNAs have become a hot topic in cancer research due to their potential for cancer detection and treatment. Their stability in various biological samples and their abnormal expression in cancer make them particularly attractive for ovarian cancer research.
Factors Driving the MicroRNA Market
The microRNA market is driven by several factors. Firstly, the increasing number of clinical trials for chronic diseases linked to miRNAs is fueling market growth. The demand for accurate and early diagnosis, along with personalized therapeutics, is also propelling the market for miRNA-based products and services. This trend aligns with the growing focus on personalized medicine, which tailors treatment plans based on individual patients' molecular profiles.
Challenges and Opportunities in the MicroRNA Market
However, safety and toxicity concerns associated with miRNA-based services are a hurdle to market growth. Conversely, advancements in technology present exciting opportunities. Next-generation sequencing (NGS) techniques enable rapid and affordable profiling of miRNA expression patterns, facilitating the discovery of novel miRNAs, identification of their targets, and characterization of their functions.
Geographic Landscape of the MicroRNA Market
The report segments the market geographically into North America, Europe, Asia Pacific, and the Rest of the World (ROW). North America is expected to hold a significant share due to a surge in clinical trials, particularly in the USA, driven by the exploration of novel therapies and diagnostics. Additionally, the presence of major market players in the region further contributes to its growth.
The Asia Pacific region is anticipated to witness the fastest growth rate. The high prevalence of diseases like cancer, cardiovascular conditions, and infectious diseases in this region creates a rising demand for specialized diagnostic techniques and treatments. MiRNAs hold promise as disease-specific biomarkers and therapeutic targets, making them valuable tools for both diagnosis and treatment in this region.
To Know More Visit: https://tinyurl.com/2b9jlvys
A Deep Dive into Market Segments
The report offers a breakdown of the market based on product and service, application, and end user. Product and service categories include profiling, localization, and quantification. Applications include cancer and neurological diseases. Pharma & biotech companies, academic & research institutes, healthcare facilities, and others are categorized as end users.
Market Keyplayers:
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Horizon Discovery Ltd.
- QIAGEN
- GeneCopoeia, Inc.
- New England Biolabs
- Quantabio
- NanoString Technologies, Inc.
- BioGenex
- SeqMatic LLC.
Contact Us:
Infinium Global Research LLP
Mob: +91 9923950043
Comments
Post a Comment